GSK updates total voting rights for July 2026
GSK plc reported its share capital and voting rights position as at 31 July 2026 in line with Financial Conduct Authority disclosure requirements.
Rhea-AI Filing Summary
GSK plc reported its share capital and voting rights position as at 31 July 2026 in line with Financial Conduct Authority disclosure requirements.
The company had 4,316,292,310 Ordinary Shares of 31¼ pence each in issue, of which 270,881,064 were held in Treasury. This results in 4,045,411,246 total voting rights, which shareholders may use as the denominator when assessing whether they must notify interests or changes in interests under the Disclosure Guidance and Transparency Rules.
Positive
- None.
Negative
- None.
Key Figures
Issued share capital: 4,316,292,310 Ordinary Shares
Treasury shares: 270,881,064 Ordinary Shares
Total voting rights: 4,045,411,246
+1 more
4 metrics
Issued share capital
4,316,292,310 Ordinary Shares
Number of Ordinary Shares in issue as at 31 July 2026
Treasury shares
270,881,064 Ordinary Shares
Ordinary Shares held in Treasury as at 31 July 2026
Total voting rights
4,045,411,246
Total number of voting rights in the company as at 31 July 2026
Nominal share value
31¼ pence
Nominal value per Ordinary Share in issued share capital
Key Terms
total voting rights, Treasury, Disclosure Guidance and Transparency Rules, Foreign private issuer
4 terms
total voting rights financial
"the total number of voting rights in the Company is 4,045,411,246"
The total voting rights number is the count of shares that carry the right to vote at a company’s shareholder meetings, reflecting how much voting power exists in the market. Investors use it to understand control and influence—like knowing how many votes are in play when measuring ownership stakes, calculating a shareholder’s voting percentage, or assessing how easy it would be for a holder to sway decisions.
Treasury financial
"of which 270,881,064 Ordinary Shares were held in Treasury"
The treasury is the department or area within a government or organization responsible for managing its money, finances, and financial strategies. It handles tasks like collecting revenue, paying bills, and planning for future financial needs, much like a household manages its budget. For investors, understanding the treasury is important because it influences interest rates, government spending, and overall economic stability.
Disclosure Guidance and Transparency Rules regulatory
"under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules"
Disclosure guidance and transparency rules are the standards and regulations that require companies to share clear, timely information about their finances, risks, operations and material events. They matter to investors because consistent, honest reporting is like a car’s dashboard — it reveals the data you need to judge safety and performance and make informed buying or selling decisions. Strong disclosure reduces surprises and helps keep markets fair and efficient.
Foreign private issuer regulatory
"REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What total voting rights did GSK (GSK) report as of 31 July 2026?
GSK reported 4,045,411,246 total voting rights as of 31 July 2026. Shareholders may use this figure as the denominator when determining whether they must notify interests or changes under UK Disclosure Guidance and Transparency Rules.
What regulatory framework governs GSK’s (GSK) voting rights disclosure?
The disclosure is made in conformity with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rule 5.6.1R. This framework sets out when issuers must notify the market about changes in total voting rights and share capital.
AI-generated analysis. How Rhea-AI works. Not financial advice.
